Showing results (71-80 of 233) with videos related to

Sort By:
Pageof 24
Cancer Immunology, Immunotherapy : CII|June 28, 2025
Simultaneous TGF-β and GITR pathway modulation promotes anti-tumor immunity in gliomaDaniela Lorizio, Manuela Silginer, Julia Friesen, et al.
Praxis|March 17, 2016
[Gliomas – What I Have to Know in ten Questions]Wiebke Gulden-Sala, Patrick Roth, Michelle Brown, et al.
Journal of Neuro-Oncology|July 7, 2026
Intratumoral hemorrhage in patients with brain metastasis from systemic tumors: risk factors and prognostic assessmentBettina Grossenbacher, Emilie Le Rhun, Patrick Roth, et al.
Multiple Sclerosis and Related Disorders|March 27, 2025
Distinct clinical, imaging, and cerebrospinal fluid profiles in people with late-onset multiple sclerosisLukas Steinegger, Veronika Kana, Nathalie Nierobisch, et al.
Journal of Neuro-Oncology|April 2, 2020
End-of-life care for glioma patients; the caregivers' perspectiveCaroline Hertler, Günter Eisele, Dorothee Gramatzki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2009
SC68896, a novel small molecule proteasome inhibitor, exerts antiglioma activity in vitro and in vivoPatrick Roth, Maria Kissel, Caroline Herrmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2019
Therapeutic Targeting of TGFβ Ligands in Glioblastoma Using Novel Antisense Oligonucleotides Reduces the Growth of Experimental GliomasAlexandros Papachristodoulou, Manuela Silginer, Michael Weller, et al.
Journal of Neurochemistry|February 27, 2018
Transcriptional control of O6 -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastomaCaroline Happold, Nina Stojcheva, Manuela Silginer, et al.
Journal of Neuro-Oncology|November 7, 2008
ACNU-based chemotherapy for recurrent glioma in the temozolomide eraCaroline Happold, Patrick Roth, Wolfgang Wick, et al.
Multiple Sclerosis and Related Disorders|December 19, 2025
Relapse activity during pregnancy and the postpartum year is associated with accelerated disability progression in multiple sclerosisLea I Walter, Veronika Kana, Sarah Hösli, et al.
Pageof 24